Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CCR5 | P51681 | 5/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL120122 | 0.81 | ALDH1A1 (0.39) | FAAHTRPV1TSHRALDH1A1 | |
| SCHEMBL119856 | 0.81 | ALDH1A1 (0.39) | FAAHTRPV1TSHRALDH1A1 | |
| SCHEMBL20853080 | 0.81 | ALDH1A1 (0.39) | FAAHTRPV1TSHRALDH1A1 | |
| SCHEMBL1771016 | 0.81 | ALDH1A1 (0.39) | FAAHTRPV1TSHRALDH1A1 | |
| SCHEMBL27771224 | 0.79 | FAAH (0.40) | FAAHTRPV1TSHRALDH1A1 | |
| SCHEMBL486953 | 0.76 | ALDH1A1 (0.38) | FAAHTRPV1TSHRALDH1A1 | |
| SCHEMBL486952 | 0.76 | ALDH1A1 (0.38) | FAAHTRPV1TSHRALDH1A1 | |
| SCHEMBL486954 | 0.76 | ALDH1A1 (0.38) | FAAHTRPV1TSHRALDH1A1 | |
| SCHEMBL28635483 | 0.75 | ALDH1A1 (0.50) | FAAHTRPV1TSHRALDH1A1 | |
| SCHEMBL26553331 | 0.75 | ALDH1A1 (0.50) | FAAHTRPV1TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210139435-A1 | PROSTAGLANDIN ANALOGS AND USES THEREOF | Lifex Biolabs, Inc. | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139435-A1 | PROSTAGLANDIN ANALOGS AND USES THEREOF | PTGDR, NR3C1, PTGIR | FAAH 1388/4885TRPV1 1308/4885TSHR 218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.